Lost earnings from those who have died of overdoses were a major factor, according to the Society of Actuaries.

The nation’s three dominant drug distributors and a big drugmaker have reached a $260 million deal to settle an opioid crisis lawsuit just as the first federal trial over the crisis was due to begin.

Roughly 5% of the state’s babies are born with neonatal abstinence syndrome. Families taking them in say they feel unprepared for the task.

About 85% of the children in state custody have a parent who struggles with substance use disorder. The system is straining to care for them.

To battle opioid overdoses, experts want businesses to think of naloxone like an EpiPen.

A proposed settlement would reportedly see the OxyContin maker declaring bankruptcy and paying big. Is that enough for people on the ground?

Johnson & Johnson is appealing the decision, which could be the first of many legal battles.

The facilities could save at least $2 million a year by reducing expensive ambulance rides, emergency room trips and hospital visits, the city says.

Purdue’s promotions exaggerated the drug’s safety and risks of addiction, leaning heavily on one sentence used by sales reps to market the drug to doctors.